Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Aronin, Steven I.
110  Ergebnisse:
Personensuche X
?
1

2568. Characterization of Sulopenem Pharmacokinetics-Pharma..:

VanScoy, Brian D ; Jones, Sean ; Conde, Haley...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
2

2569. Pharmacokinetic-Pharmacodynamic Evaluation of Sulopen..:

VanScoy, Brian D ; Conde, Haley ; Vincent, Catherine E...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
3

In vitro activity of sulopenem and comparator agents agains..:

Maher, Joshua M ; Huband, Michael D ; Blankers, Christopher G...
Journal of Antimicrobial Chemotherapy.  78 (2023)  6 - p. 1406-1414 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Applying Desirability of Outcome Ranking End Points:

Dunne, Michael W ; Aronin, Steven I ; Das, Anita F...
Clinical Infectious Diseases.  77 (2023)  1 - p. 159-161 , 2023
Link: https://doi.org/10.1093/..
 
?
5

2106. Desirability of Outcome Ranking (DOOR): Application t..:

Aronin, Steven I ; Dunne, Michael W ; Gupta, Jayanti.
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
6

Applying Desirability of Outcome Ranking End Point to Rando..:

Dunne, Michael W ; Aronin, Steven I ; Das, Anita F...
Clinical Infectious Diseases.  76 (2023)  12 - p. 2213-2215 , 2023
Link: https://doi.org/10.1093/..
 
?
7

Sulopenem Disk Development, Quality Control Range, and MIC ..:

Puttagunta, Sailaja ; Aronin, Steven I. ; DiFranco-Fisher, Jeanna..
Journal of Clinical Microbiology.  61 (2023)  7 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
8

Regional Differences in Antibiotic-resistant Enterobacteral..:

Aronin, Steven I. ; Gupta, Vikas ; Dunne, Michael W...
International Journal of Infectious Diseases.  119 (2022)  - p. 142-145 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Impact of Empirical Antibiotic Therapy on Outcomes of Outpa..:

Dunne, Michael W. ; Puttagunta, Sailaja ; Aronin, Steven I....
Microbiology Spectrum.  10 (2022)  1 - p. , 2022
Link: https://doi.org/10.1128/..
 
?
10

A multicenter analysis of trends in resistance in urinary E..:

Dunne, Michael W. ; Aronin, Steven I. ; Yu, Kalvin C...
BMC Infectious Diseases.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
11

Sulopenem or Ciprofloxacin for the Treatment of Uncomplicat..:

Dunne, Michael W ; Aronin, Steven I ; Das, Anita F...
Clinical Infectious Diseases.  76 (2022)  1 - p. 66-77 , 2022
Link: https://doi.org/10.1093/..
 
?
12

227. Impact of Asymptomatic Bacteriuria on Primary Efficacy..:

Aronin, Steven I ; Dunne, Michael ; Puttagunta, Sailaja
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
13

1724. Murine Efficacy Studies of Sulopenem Against Bacillus..:

Puttagunta, Sailaja ; Aronin, Steven I ; Dunne, Michael...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
14

Sulopenem for the Treatment of Complicated Urinary Tract In..:

Dunne, Michael W ; Aronin, Steven I ; Das, Anita F...
Clinical Infectious Diseases.  76 (2022)  1 - p. 78-88 , 2022
Link: https://doi.org/10.1093/..
 
?
15

Increased rates of extended-spectrum beta-lactamase isolate..:

Aronin, Steven I. ; Dunne, Michael W. ; Yu, Kalvin C...
Diagnostic Microbiology and Infectious Disease.  103 (2022)  4 - p. 115717 , 2022
Link: https://doi.org/10.1016/..
 
1-15